Added to YB: 2022-07-25
Pitch date: 2022-07-25
OVID [bullish]
Ovid Therapeutics Inc.
-25.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.
Market Cap
$229.1M
Pitch Price
$2.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.96
P/E
-3.49
EV/Sales
32.87
Sector
Biotechnology
Category
N/A
Show full summary:
OVID THRPUTCS INC OVID
A summary for this pitch has not been created yet.
Read full article (0 min)